4//SEC Filing
Freund John Gordon 4
Accession 0001062993-24-010540
CIK 0001267565other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:22 PM ET
Size
7.6 KB
Accession
0001062993-24-010540
Insider Transaction Report
Form 4
Freund John Gordon
Director
Transactions
- Award
Common Stock
2024-05-16+7,693→ 52,468 total
Holdings
- 8,625(indirect: By LLC)
Common Stock
- 34,788(indirect: By Partnership)
Common Stock
Footnotes (3)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.
- [F2]The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The reporting person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.
- [F3]The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001296771
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:22 PM ET
- Size
- 7.6 KB